NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration Medical Device Investing
Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients Life Science Investing News
Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial Life Science Investing News
Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit Life Science Investing News
Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer Pharmaceutical Investing
MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 Pharmaceutical Investing
NanoVibronix Announces Selection of Leading International Contract Manufacturer Medical Device Investing
Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia Therapeutics Pharmaceutical Investing
Phivida appoints Covet Public Relations as U.S. Public Relations Agency of Record Cannabis Investing News
